Filing Details
- Accession Number:
- 0001171843-14-004630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-03 17:12:37
- Reporting Period:
- 2014-10-01
- Filing Date:
- 2014-10-03
- Accepted Time:
- 2014-10-03 17:12:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466630 | A Timothy Dick | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-01 | 61,111 | $2.61 | 184,099 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-10-01 | 61,111 | $1.46 | 245,210 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-01 | 122,222 | $35.24 | 122,988 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-01 | 61,111 | $0.00 | 61,111 | $2.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-10-01 | 61,111 | $0.00 | 61,111 | $1.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 244,445 | 2015-05-21 | No | 4 | M | Direct | |
| 61,111 | 2015-02-22 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2014.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $33.65 to $36.17 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Amount of Shares Beneficially Owned Following Reported Transaction includes 45,789 unvested shares subject to restricted stock awards and 77,199 shares owned outright.
- The option vested in three annual installments with 122,222 options vesting on each of May 21, 2011 and May 21, 2012, and 122,223 options vesting on May 21, 2013.
- The option vested in three annual installments with 61,111 vesting on each of February 22, 2011, February 22, 2012 and February 22, 2013.
- There was no consideration given in exchange for the security.
Billionaire Hedge Funds
